Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial
Year: 2025
Type: article
Language: en
Topic: Lymphoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Laurie H Sehn
raw_affiliation_strings: BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada. Electronic address: lsehn@bccancer.bc.ca
raw_author_name: Kai Hübel
raw_affiliation_strings: University of Cologne and Faculty of Medicine and University Hospital of Cologne, Cologne, Germany
raw_author_name: Stefano Luminari
raw_affiliation_strings: Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy; Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy
raw_author_name: Christian W Scholz
raw_affiliation_strings: Vivantes Klinikum Am Urban, Berlin, Germany
raw_author_name: Antonio Salar
raw_affiliation_strings: Hospital del Mar-IMIM, Barcelona, Spain
raw_author_name: Shankara Paneesha
raw_affiliation_strings: University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; University of Birmingham, Birmingham, UK
raw_author_name: Björn Engelbrekt Wahlin
raw_affiliation_strings: Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
raw_author_name: Panayiotis Panayiotidis
raw_affiliation_strings: National and Kapodistrian University of Athens Medical School, General Hospital LAIKO, Athens, Greece
raw_author_name: Hui-Peng Lee
raw_affiliation_strings: Flinders Medical Centre and Flinders University, Adelaide, South Australia, Australia
raw_author_name: Ana Jiménez-Ubieto
raw_affiliation_strings: Servicio de Hematología, Hospital 12 de Octubre, Madrid, Spain
raw_author_name: Juan-Manuel Sancho
raw_affiliation_strings: ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona, Barcelona, Spain
raw_author_name: Tae Min Kim
raw_affiliation_strings: Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea
raw_author_name: Eva Domingo Domenech
raw_affiliation_strings: Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Barcelona, Spain
raw_author_name: Takahiro Kumode
raw_affiliation_strings: Kindai University, Osaka, Japan
raw_author_name: Christina Poh
raw_affiliation_strings: Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA
raw_author_name: Catherine Thieblemont
raw_affiliation_strings: Saint-Louis Hospital, Paris, France
raw_author_name: Dries Deeren
raw_affiliation_strings: AZ Delta General Hospital, Roeselare, Belgium
raw_author_name: Edwin de Wit
raw_affiliation_strings: Incyte International Biosciences, Morges, Switzerland
raw_author_name: Michael Arbushites
raw_affiliation_strings: Incyte, Wilmington, DE, USA
raw_author_name: Irene Vassallo
raw_affiliation_strings: Incyte International Biosciences, Morges, Switzerland
raw_author_name: Marek Trneny
raw_affiliation_strings: First Faculty of Medicine, Charles University, Prague, Czech Republic
raw_author_name: Björn Engelbrekt Wahlin
raw_affiliation_strings: Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
raw_author_name: Tae Min Kim
raw_affiliation_strings: Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea
raw_author_name: Eva Domingo Domenech
raw_affiliation_strings: Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Barcelona, Spain